Home
AVDL
AVDL News

Latest Avadel Pharmaceuticals plc (AVDL) News on November 25, 2024

MT Newswires

6 days ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $22 From $25, Maintains Buy Rating

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

11 days ago

Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswire

12 days ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GuruFocus.com

12 days ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...

MT Newswires

13 days ago

Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

Associated Press Finance

13 days ago

Avadel: Q3 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

13 days ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

14 days ago

Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

GlobeNewswire

21 days ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle

Pharmaceutical Technology

24 days ago

US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term

Simply Wall St.

24 days ago

Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

GlobeNewswire

25 days ago

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

GlobeNewswire

a month ago

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Pharmaceutical Technology

a month ago

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz

Zacks

a month ago

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz

MT Newswires

a month ago

Avadel Pharmaceuticals Gets FDA Approval for Lumryz to Treat Cataplexy in Narcolepsy Patients

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

GlobeNewswire

a month ago

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

GuruFocus.com

2 months ago

Avadel Pharmaceuticals PLC (AVDL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

GlobeNewswire

2 months ago

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

GlobeNewswire

3 months ago

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

MT Newswires

3 months ago

Sector Update: Health Care

MT Newswires

3 months ago

Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

3 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Insider Monkey

3 months ago

Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension

GlobeNewswire

3 months ago

Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension

MT Newswires

3 months ago

UBS Adjusts Price Target on Avadel Pharmaceuticals to $25 From $23, Maintains Buy Rating

MT Newswires

4 months ago

Avadel Pharmaceuticals Narrows Q2 Net Loss as Product Revenue Climbs

Are Medical Stocks Lagging DaVita (DVA) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging DaVita (DVA) This Year?

Associated Press Finance

4 months ago

Avadel: Q2 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82

Investor's Business Daily

4 months ago

Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82

Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?

Zacks

4 months ago

Does Avadel (AVDL) Have the Potential to Rally 43.6% as Wall Street Analysts Expect?

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8

GlobeNewswire

4 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8

Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial

Clinical Trials Arena

4 months ago

Avadel announces first subject dosing in Phase III idiopathic hypersomnia trial

Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

GlobeNewswire

4 months ago

Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

MT Newswires

5 months ago

Avadel Pharmaceuticals to Join Russell 3000 Index Monday; Shares Rise After Hours

Avadel Pharmaceuticals to Join Russell 3000® Index

GlobeNewswire

5 months ago

Avadel Pharmaceuticals to Join Russell 3000® Index

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

Zacks

5 months ago

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?

VanEck Semiconductor ETF Is Riskier Than You Think

Motley Fool

6 months ago

VanEck Semiconductor ETF Is Riskier Than You Think

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Motley Fool

6 months ago

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Reuters

6 months ago

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Simply Wall St.

6 months ago

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

GuruFocus.com

6 months ago

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

GuruFocus.com

6 months ago

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

GuruFocus.com

6 months ago

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

GuruFocus.com

6 months ago

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

6 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors

GlobeNewswire

6 months ago

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript

MT Newswires

7 months ago

Avadel Pharmaceuticals Q1 Loss Narrows

Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...

GuruFocus.com

7 months ago

Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...

Associated Press Finance

7 months ago

Avadel: Q1 Earnings Snapshot

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

7 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

GlobeNewswire

7 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know

Zacks

7 months ago

Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know

11 Best Low Price Pharma Stocks To Invest In

Insider Monkey

7 months ago

11 Best Low Price Pharma Stocks To Invest In

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future

Simply Wall St.

7 months ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near Future

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

GlobeNewswire

8 months ago

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

9 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals Issues Statement On Patent Litigation

GlobeNewswire

9 months ago

Avadel Pharmaceuticals Issues Statement On Patent Litigation

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

9 months ago

Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing

Simply Wall St.

9 months ago

With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4

GlobeNewswire

9 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4

Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

10 months ago

Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

Business Wire

10 months ago

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

First Financial Bank and National Community Reinvestment Coalition Announce $2.4 Billion Community Benefits Agreement

PR Newswire

10 months ago

First Financial Bank and National Community Reinvestment Coalition Announce $2.4 Billion Community Benefits Agreement

Thoughtworks Named a Top 15 Sourcing Standout by ISG

Business Wire

10 months ago

Thoughtworks Named a Top 15 Sourcing Standout by ISG

Investors in Rogers (NYSE:ROG) have unfortunately lost 25% over the last three years

Simply Wall St.

10 months ago

Investors in Rogers (NYSE:ROG) have unfortunately lost 25% over the last three years

First Citizens BancShares, Inc. (NASDAQ:FCNCA) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

First Citizens BancShares, Inc. (NASDAQ:FCNCA) Q4 2023 Earnings Call Transcript

BankUnited Inc (BKU) Reports Decline in Quarterly and Annual Net Income Amid Strategic Balance ...

GuruFocus.com

10 months ago

BankUnited Inc (BKU) Reports Decline in Quarterly and Annual Net Income Amid Strategic Balance ...

Columbia Financial (CLBK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

10 months ago

Columbia Financial (CLBK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Mexico's Televisa close to launching sports and gaming spin-off

Reuters

10 months ago

Mexico's Televisa close to launching sports and gaming spin-off

3 Mid-Cap Energy Stocks Investors Can Buy Right Now

Zacks

10 months ago

3 Mid-Cap Energy Stocks Investors Can Buy Right Now

Is It Too Late to Buy Dutch Bros Stock?

Motley Fool

10 months ago

Is It Too Late to Buy Dutch Bros Stock?

Pathward Financial, Inc. Announces Results for 2024 Fiscal First Quarter

Business Wire

10 months ago

Pathward Financial, Inc. Announces Results for 2024 Fiscal First Quarter

Why Veeco (VECO) Could Beat Earnings Estimates Again

Zacks

10 months ago

Why Veeco (VECO) Could Beat Earnings Estimates Again

3 High-Potential Stocks That Can Turn $10K to $20K in 2024

InvestorPlace

10 months ago

3 High-Potential Stocks That Can Turn $10K to $20K in 2024

LIBERTY LATIN AMERICA ANNOUNCES EXECUTIVE TEAM CHANGES

Business Wire

10 months ago

LIBERTY LATIN AMERICA ANNOUNCES EXECUTIVE TEAM CHANGES

Here's Why You Should Invest in Avadel (AVDL) Stock Now

Zacks

10 months ago

Here's Why You Should Invest in Avadel (AVDL) Stock Now

Shareholders have faith in loss-making Avadel Pharmaceuticals (NASDAQ:AVDL) as stock climbs 5.0% in past week, taking five-year gain to 516%

Simply Wall St.

10 months ago

Shareholders have faith in loss-making Avadel Pharmaceuticals (NASDAQ:AVDL) as stock climbs 5.0% in past week, taking five-year gain to 516%

Compass Diversified Promises Faster Growth to Investors

Barrons.com

10 months ago

Compass Diversified Promises Faster Growth to Investors

Is Now An Opportune Moment To Examine Liberty Latin America Ltd. (NASDAQ:LILA)?

Simply Wall St.

10 months ago

Is Now An Opportune Moment To Examine Liberty Latin America Ltd. (NASDAQ:LILA)?

Mercury Systems to Report Second Quarter Fiscal Year 2024 Financial Results on February 6, 2024

GlobeNewswire

10 months ago

Mercury Systems to Report Second Quarter Fiscal Year 2024 Financial Results on February 6, 2024

Avadel (AVDL) is a Great Momentum Stock: Should You Buy?

Zacks

10 months ago

Avadel (AVDL) is a Great Momentum Stock: Should You Buy?

How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%

Zacks

10 months ago

How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%

Synaptics to Participate at Upcoming Investor Conference Thursday, January 18, 2024

GlobeNewswire

10 months ago

Synaptics to Participate at Upcoming Investor Conference Thursday, January 18, 2024

16 Best Mid-Cap Growth Stocks To Buy Now

Insider Monkey

10 months ago

16 Best Mid-Cap Growth Stocks To Buy Now

Why Avadel Pharmaceuticals (AVDL) Stock Might be a Great Pick

Zacks

10 months ago

Why Avadel Pharmaceuticals (AVDL) Stock Might be a Great Pick

Why Neumora Therapeutics (NMRA) Stock Might be a Great Pick

Zacks

10 months ago

Why Neumora Therapeutics (NMRA) Stock Might be a Great Pick

Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights

GlobeNewswire

a year ago

Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights

Semrush Holdings, Inc. to Present at Needham Growth Conference

Business Wire

a year ago

Semrush Holdings, Inc. to Present at Needham Growth Conference

Is Now An Opportune Moment To Examine Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Simply Wall St.

a year ago

Is Now An Opportune Moment To Examine Sapiens International Corporation N.V. (NASDAQ:SPNS)?

Rover Announces Expiration of “Go-Shop” Period

GlobeNewswire

a year ago

Rover Announces Expiration of “Go-Shop” Period

Amicus (FOLD) Banks on Galafold, Overdependence a Concern

Zacks

a year ago

Amicus (FOLD) Banks on Galafold, Overdependence a Concern

Zacks Industry Outlook Highlights Federal Agricultural Mortgage, LendingTree and Ocwen Financial

Zacks

a year ago

Zacks Industry Outlook Highlights Federal Agricultural Mortgage, LendingTree and Ocwen Financial

Amneal Announces Move to Nasdaq

Business Wire

a year ago

Amneal Announces Move to Nasdaq

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

GlobeNewswire

a year ago

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

Investing in Apollo Medical Holdings (NASDAQ:AMEH) five years ago would have delivered you a 99% gain

Simply Wall St.

a year ago

Investing in Apollo Medical Holdings (NASDAQ:AMEH) five years ago would have delivered you a 99% gain

Share on Social Networks: